Advertisement
RCUS vs SYRE
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCUS is a Hold and SYRE is a Buy.
SYRE | RCUS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 84 | 76 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 68 Overvalued | 71 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 96 | 98 | |
PRICE GROWTH RATING 1..100 | 35 | 55 | |
P/E GROWTH RATING 1..100 | 71 | 98 | |
SEASONALITY SCORE 1..100 | 33 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SYRE's Valuation (68) in the Pharmaceuticals Major industry is in the same range as RCUS (71). This means that SYRE’s stock grew similarly to RCUS’s over the last 12 months.
SYRE's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as RCUS (100). This means that SYRE’s stock grew similarly to RCUS’s over the last 12 months.
SYRE's SMR Rating (96) in the Pharmaceuticals Major industry is in the same range as RCUS (98). This means that SYRE’s stock grew similarly to RCUS’s over the last 12 months.
SYRE's Price Growth Rating (35) in the Pharmaceuticals Major industry is in the same range as RCUS (55). This means that SYRE’s stock grew similarly to RCUS’s over the last 12 months.
SYRE's P/E Growth Rating (71) in the Pharmaceuticals Major industry is in the same range as RCUS (98). This means that SYRE’s stock grew similarly to RCUS’s over the last 12 months.
| RCUS | SYRE | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 64% | 7 days ago 89% |
| Stochastic ODDS (%) | 1 day ago 80% | 1 day ago 86% |
| Momentum ODDS (%) | 1 day ago 78% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 76% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 80% | 1 day ago 87% |
| TrendMonth ODDS (%) | 1 day ago 77% | 1 day ago 87% |
| Advances ODDS (%) | 14 days ago 78% | 1 day ago 87% |
| Declines ODDS (%) | 12 days ago 78% | 8 days ago 87% |
| BollingerBands ODDS (%) | 1 day ago 74% | 1 day ago 84% |
| Aroon ODDS (%) | 1 day ago 79% | 1 day ago 87% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
SYRE’s FA Score shows that 0 FA rating(s) are green while RCUS’s FA Score has 0 green FA rating(s).
- SYRE’s FA Score: 0 green, 5 red.
- RCUS’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
RCUS’s TA Score shows that 5 TA indicator(s) are bullish while SYRE’s TA Score has 5 bullish TA indicator(s).
- RCUS’s TA Score: 5 bullish, 5 bearish.
- SYRE’s TA Score: 5 bullish, 3 bearish.
Price Growth
RCUS (@Biotechnology) experienced а -1.62% price change this week, while SYRE (@Biotechnology) price change was -7.36% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -5.09%. For the same industry, the average monthly price growth was -11.53%, and the average quarterly price growth was -11.77%.
Reported Earning Dates
RCUS is expected to report earnings on Nov 10, 2026.
SYRE is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Biotechnology (-5.09% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| STLU | 17.97 | 0.99 | +5.83% |
| Volatility Shares 2x Stellar ETF (STLU) | |||
| CSHP | 99.43 | -0.08 | -0.08% |
| iShares Dynamic Short-Term Active ETF (CSHP) | |||
| CCFE | 24.06 | -0.03 | -0.12% |
| Concourse Capital Focused Equity ETF (CCFE) | |||
| SPGM | 87.32 | -0.12 | -0.14% |
| State Street SPDR Portfolio MSCI Global Stock Market ETF (SPGM) | |||
| SBI | 7.07 | -0.05 | -0.70% |
| Western Asset Intermediate Muni Fund | |||
RCUS and Stocks
Correlation & Price change
A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with VIR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then VIR could also see price increases.
| Ticker / NAME | Correlation To RCUS | 1D Price Change % | ||
|---|---|---|---|---|
| RCUS | 100% | -0.29% | ||
| VIR - RCUS | 49% Loosely correlated | -3.42% | ||
| XNCR - RCUS | 49% Loosely correlated | +1.66% | ||
| KURA - RCUS | 46% Loosely correlated | -1.93% | ||
| NRIX - RCUS | 44% Loosely correlated | -0.85% | ||
| BCAX - RCUS | 44% Loosely correlated | -0.97% | ||
More | ||||
SYRE and Stocks
Correlation & Price change
A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with ORKA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then ORKA could also see price increases.
| Ticker / NAME | Correlation To SYRE | 1D Price Change % | ||
|---|---|---|---|---|
| SYRE | 100% | +0.25% | ||
| ORKA - SYRE | 54% Loosely correlated | -2.14% | ||
| IMVT - SYRE | 45% Loosely correlated | -3.25% | ||
| BEAM - SYRE | 45% Loosely correlated | -2.22% | ||
| PMN - SYRE | 44% Loosely correlated | -0.62% | ||
| RCKT - SYRE | 44% Loosely correlated | -3.12% | ||
More | ||||